Literature DB >> 26258435

Model Peptide Studies Reveal a Mixed Histidine-Methionine Cu(I) Binding Site at the N-Terminus of Human Copper Transporter 1.

M Jake Pushie1,2, Katharine Shaw3, Katherine J Franz4, Jason Shearer5, Kathryn L Haas3.   

Abstract

Copper is a vital metal cofactor in enzymes that are essential to myriad biological processes. Cellular acquisition of copper is primarily accomplished through the Ctr family of plasma membrane copper transport proteins. Model peptide studies indicate that the human Ctr1 N-terminus binds to Cu(II) with high affinity through an amino terminal Cu(II), Ni(II) (ATCUN) binding site. Unlike typical ATCUN-type peptides, the Ctr1 peptide facilitates the ascorbate-dependent reduction of Cu(II) bound in its ATCUN site by virtue of an adjacent HH (bis-His) sequence in the peptide. It is likely that the Cu(I) coordination environment influences the redox behavior of Cu bound to this peptide; however, the identity and coordination geometry of the Cu(I) site has not been elucidated from previous work. Here, we show data from NMR, XAS, and structural modeling that sheds light on the identity of the Cu(I) binding site of a Ctr1 model peptide. The Cu(I) site includes the same bis-His site identified in previous work to facilitate ascorbate-dependent Cu(II) reduction. The data presented here are consistent with a rational mechanism by which Ctr1 provides coordination environments that facilitate Cu(II) reduction prior to Cu(I) transport.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26258435     DOI: 10.1021/acs.inorgchem.5b01162

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  9 in total

1.  Gene duplication and neo-functionalization in the evolutionary and functional divergence of the metazoan copper transporters Ctr1 and Ctr2.

Authors:  Brandon L Logeman; L Kent Wood; Jaekwon Lee; Dennis J Thiele
Journal:  J Biol Chem       Date:  2017-05-15       Impact factor: 5.157

Review 2.  Copper trafficking to the secretory pathway.

Authors:  Svetlana Lutsenko
Journal:  Metallomics       Date:  2016-09-05       Impact factor: 4.526

3.  Multinuclear Metal-Binding Ability of the N-Terminal Region of Human Copper Transporter Ctr1: Dependence Upon pH and Metal Oxidation State.

Authors:  Maria Incoronata Nardella; Mariagrazia Fortino; Alessandra Barbanente; Giovanni Natile; Adriana Pietropaolo; Fabio Arnesano
Journal:  Front Mol Biosci       Date:  2022-05-05

4.  Sequence proximity between Cu(II) and Cu(I) binding sites of human copper transporter 1 model peptides defines reactivity with ascorbate and O2.

Authors:  Stefanie Schwab; Jason Shearer; Steven E Conklin; Bruno Alies; Kathryn L Haas
Journal:  J Inorg Biochem       Date:  2015-12-30       Impact factor: 4.155

5.  Specific Histidine Residues Confer Histatin Peptides with Copper-Dependent Activity against Candida albicans.

Authors:  Steven E Conklin; Emma C Bridgman; Qiang Su; Pamela Riggs-Gelasco; Kathryn L Haas; Katherine J Franz
Journal:  Biochemistry       Date:  2017-08-01       Impact factor: 3.162

6.  X-ray structures of the high-affinity copper transporter Ctr1.

Authors:  Feifei Ren; Brandon L Logeman; Xiaohui Zhang; Yongjian Liu; Dennis J Thiele; Peng Yuan
Journal:  Nat Commun       Date:  2019-03-27       Impact factor: 14.919

Review 7.  Structural and Functional Diversity Among the Members of CTR, the Membrane Copper Transporter Family.

Authors:  Taniya Mandal; Sumanta Kar; Saptarshi Maji; Samarpita Sen; Arnab Gupta
Journal:  J Membr Biol       Date:  2020-09-25       Impact factor: 1.843

8.  Oxidase Reactivity of CuII Bound to N-Truncated Aβ Peptides Promoted by Dopamine.

Authors:  Chiara Bacchella; Simone Dell'Acqua; Stefania Nicolis; Enrico Monzani; Luigi Casella
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

9.  A Deeper Insight in Metal Binding to the hCtr1 N-terminus Fragment: Affinity, Speciation and Binding Mode of Binuclear Cu2+ and Mononuclear Ag+ Complex Species.

Authors:  Antonio Magrì; Giovanni Tabbì; Irina Naletova; Francesco Attanasio; Giuseppe Arena; Enrico Rizzarelli
Journal:  Int J Mol Sci       Date:  2022-03-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.